AVR 7.92% $15.70 anteris technologies ltd

Ann: AGM Chairman Address and CEO Presentation, page-26

  1. 207 Posts.
    lightbulb Created with Sketch. 29
    Apologies for fragmented post.

    The clinical results from the recent trials do provide evidence of the pre - post clinical findings (impressive and significant improvements achieved with the DURAVR). The clinical results also show superiority over the competitors products...specifically, the mechanical readings - area of valve and pressure gradient.

    The cited article (sample of 80 in two groups - mechanical v bioprosthetic valves) highlited a difference between the two......particularly with the exercise tollerence results......the patients recieving the mechanical valve achieved significant improvements in the 6 minute walk test, yet the bioprosthetic valve shows no improvement.

    Perhaps this is another area of superiority our product has - the bioprosthetic valve space.
 
watchlist Created with Sketch. Add AVR (ASX) to my watchlist
(20min delay)
Last
$15.70
Change
-1.350(7.92%)
Mkt cap ! $301.7M
Open High Low Value Volume
$16.50 $16.50 $15.52 $571.1K 35.69K

Buyers (Bids)

No. Vol. Price($)
1 13 $15.58
 

Sellers (Offers)

Price($) Vol. No.
$16.00 775 2
View Market Depth
Last trade - 16.10pm 24/07/2024 (20 minute delay) ?
AVR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.